Works matching IS 11732563 AND DT 2023 AND VI 43 AND IP 8

Results: 8

Tislelizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy as First-Line Treatment for Chinese Patients with Advanced Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 8, p. 643, doi. 10.1007/s40261-023-01295-2

By:

Lu, Shijie;
Lou, Yake;
Rong, Yi;
Huang, Zirui;
Lin, Xiaodan;
Chen, Junying;
Luo, Kongjia

Publication type:

Article

Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 8, p. 579, doi. 10.1007/s40261-023-01284-5

By:

Corominas, Héctor;
Young, David;
Cummings, J. R. Fraser;
Bouhnik, Yoram;
Armuzzi, Alessandro;
Thaci, Diamant;
Kim, Jihyun

Publication type:

Article

Avacopan, a Novel Competitive C5a Receptor Antagonist, for Severe Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 8, p. 595, doi. 10.1007/s40261-023-01298-z

By:

Nguyen, Ivan D.;
Sinnathamby, Evan S.;
Mason, Joseph;
Urban, Bretton;
Neuchat, Elisa E.;
Wenger, Danielle M.;
Ahmadzadeh, Shahab;
Shekoohi, Sahar;
Kaye, Alan D.

Publication type:

Article

Does Opioid Use Disorder Matter for Health Care Utilization Among Lung Cancer Patients? Evidence from U.S. Hospitals During 2016–2020.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 8, p. 635, doi. 10.1007/s40261-023-01297-0

By:

Park, Jeong-Hui;
Kim, Sun Jung;
Grajeda, Lily;
Ramirez, Alexiya;
Chang, Jongwha

Publication type:

Article

Correction to: Olipudase Alfa in Non-CNS Manifestations of Acid Sphingomyelinase Deficiency: A Profile of Its Use.

Published in:

2023

By:

Syed, Yahiya Y.

Publication type:

Correction Notice

Evaluating the Association of Montelukast Use on Neuropsychiatry-Related Healthcare Utilization and Depression in COVID-19-Hospitalized Veterans: A Nationwide VA Observational Cohort Study.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 8, p. 605, doi. 10.1007/s40261-023-01292-5

By:

Patil, Tanvi;
Raguindin, Jasper Jade;
Radtke, Michelle;
Smigiel, Joseph;
Savona, Natalie;
Kavuru, Bush;
Sekhri, Anuradha

Publication type:

Article

Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 8, p. 621, doi. 10.1007/s40261-023-01285-4

By:

Chauca Strand, Gabriella;
Johansson, Naimi;
Jakobsson, Niklas;
Bonander, Carl;
Svensson, Mikael

Publication type:

Article

Absorption, Metabolism, and Excretion of [<sup>14</sup>C]-Tolebrutinib After Oral Administration in Humans, Contribution of the Metabolites to Pharmacological Activity.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 8, p. 653, doi. 10.1007/s40261-023-01296-1

By:

Nicolas, Olivier;
Moliner, Patricia;
Soubayrol, Patrick;
Vitse, Olivier;
Roy, Sebastien;
Cabanis, Marie-José;
Turner, Tim;
Klieber, Sylvie;
Muccio, Stephane;
Arabeyre, Catherine;
Brun, Priscilla

Publication type:

Article